SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-160766 from GE HealthCare Technologies Inc. (GEHC) (CIK 0001932393) (GEHC)

GE HealthCare Technologies Inc. (GEHC) (CIK 0001932393)
Date: June 5, 2023 · CIK: 0001932393 · Accession: 0001193125-23-160766

AI Filing Summary & Sentiment

File numbers found in text: 333-272419

Date
June 5, 2023
Author
EVERCORE GROUP L.L.C.
Form
CORRESP
Company
GE HealthCare Technologies Inc. (GEHC) (CIK 0001932393)

Letter

VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Washington, DC 20549-6010 Attention: Jessica Ansart Re: GE HealthCare Technologies Inc. Registration Statement on Form S-1 (File No. 333-272419)

Dear Ms. Ansart:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Evercore Group L.L.C. and Morgan Stanley & Co. LLC, as representatives of the several underwriters, hereby join in the request of GE HealthCare Technologies Inc. that the effective date of the Registration Statement on Form S-1 (File No. 333-272419) (the “Registration Statement”) be accelerated and that it be declared effective June 7, 2023 at 4:00 p.m. Eastern time, or as soon as practicable thereafter.

Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

We have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.

[Signature Page Follows]

Very truly yours,
EVERCORE GROUP L.L.C.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 June 5, 2023

VIA EDGAR

 U.S. Securities and Exchange
Commission

 Division of Corporation Finance

 Office of
Industrial Applications and Services

 100 F Street, N.E.

Washington, DC 20549-6010

 Attention: Jessica Ansart

Re:
 GE HealthCare Technologies Inc.

 Registration Statement on Form S-1 (File
No. 333-272419)

 Dear Ms. Ansart:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Evercore Group L.L.C. and Morgan
Stanley & Co. LLC, as representatives of the several underwriters, hereby join in the request of GE HealthCare Technologies Inc. that the effective date of the Registration Statement on Form S-1
(File No. 333-272419) (the “Registration Statement”) be accelerated and that it be declared effective June 7, 2023 at 4:00 p.m. Eastern time, or as soon as practicable thereafter.

Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary
prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

 We
have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.

[Signature Page Follows]

Very truly yours,

 EVERCORE GROUP L.L.C.

 MORGAN
STANLEY & CO. LLC

 Acting severally on behalf of themselves and the several Underwriters

By:

EVERCORE GROUP L.L.C.

By:

/s/ Sachin Aggarwal

Name:

Sachin Aggarwal

Title:

Senior Managing Director

By:

MORGAN STANLEY & CO. LLC

By:

/s/ Daniel J. F. McCullough

Name:

Daniel J. F. McCullough

Title:

Vice President

 [Signature Page to Request for Acceleration of Effectiveness]